Nitric Oxide Alleviated High Salt-Induced Cardiomyocyte Apoptosis and Autophagy Independent of Blood Pressure in Rats

Yong Li1, Xiaoguang Wu1, Yukang Mao1

  • 1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Insights

High-salt diet causes cardiac damage and cell death, independent of blood pressure. Nitric oxide (NO) supplementation can protect heart cells from this damage by reducing apoptosis and autophagy.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Cellular Biology

Background:

  • High-salt diet (HSD) is linked to cardiovascular disease.
  • The direct impact of HSD on cardiac damage, independent of blood pressure, requires further investigation.
  • The role of nitric oxide (NO) in mitigating HSD-induced cardiac cellular stress is not fully understood.

Purpose of the Study:

  • To determine if HSD induces cardiac damage independently of blood pressure.
  • To investigate the effect of NO on high-salt-induced cardiomyocyte apoptosis and autophagy.

Main Methods:

  • Rats were subjected to an 8% HSD.
  • H9C2 cells and primary neonatal rat cardiomyocytes (NRCM) were treated with sodium chloride (NaCl) in vitro.
  • Levels of apoptosis markers (cleaved-caspase 3/8, Bax/Bcl2) and autophagy markers (LC3 II/I, Beclin-1, ATG7) were measured.
  • Nitric oxide donor sodium nitroprusside (SNP) was used to assess NO's protective effects.

Main Results:

  • HSD increased cardiac apoptosis and autophagy markers in rats, irrespective of hypertension status.
  • NaCl treatment elevated apoptosis and autophagy markers in H9C2 cells and NRCM.
  • NO levels were reduced in HSD rats, while eNOS expression was altered.
  • SNP administration reversed NaCl-induced apoptosis and autophagy in vitro and in vivo, without affecting blood pressure in hypertension-resistant rats.

Conclusions:

  • High-salt diet promotes cardiac damage and cellular stress (apoptosis and autophagy) independently of elevated blood pressure.
  • Exogenous nitric oxide supplementation can effectively alleviate high-salt-induced cardiomyocyte apoptosis and autophagy.
  • These findings highlight NO's potential therapeutic role in managing salt-induced cardiac pathology.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.5K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
645
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.9K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
276